Krystal Biotech Files 8-K for Regulation FD Disclosure
Ticker: KRYS · Form: 8-K · Filed: Jul 25, 2025 · CIK: 1711279
| Field | Detail |
|---|---|
| Company | Krystal Biotech, Inc. (KRYS) |
| Form Type | 8-K |
| Filed Date | Jul 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulation-fd
TL;DR
Krystal Biotech filed an 8-K for a Reg FD disclosure on 7/25/25. No specific details provided.
AI Summary
Krystal Biotech, Inc. filed an 8-K on July 25, 2025, to report a Regulation FD Disclosure. The filing does not contain specific financial figures or event details beyond its nature as a disclosure.
Why It Matters
This filing indicates Krystal Biotech is making a public disclosure under Regulation FD, ensuring all investors receive material information simultaneously. The specific content of the disclosure is not detailed in this summary.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure and does not contain information that inherently increases risk.
Key Players & Entities
- Krystal Biotech, Inc. (company) — Registrant
- July 25, 2025 (date) — Date of Report
- Regulation FD (regulation) — Disclosure Type
FAQ
What is the specific nature of the Regulation FD Disclosure being made by Krystal Biotech, Inc. on July 25, 2025?
The provided filing summary does not specify the content of the Regulation FD Disclosure; it only states that such a disclosure was made.
Does this 8-K filing contain any financial results or material business updates for Krystal Biotech, Inc.?
No, the filing summary indicates this 8-K is for a Regulation FD Disclosure and does not mention specific financial results or business updates.
What is the principal executive office address for Krystal Biotech, Inc.?
The principal executive offices are located at 2100 Wharton Street, Suite 701, Pittsburgh, Pennsylvania 15203.
Under which section of the Securities Exchange Act of 1934 is this 8-K report filed?
This 8-K report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the SIC code for Krystal Biotech, Inc.?
The Standard Industrial Classification (SIC) code for Krystal Biotech, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 25, 2025 regarding Krystal Biotech, Inc. (KRYS).